EG665149 inhibitors represent a class of chemical compounds known primarily for their ability to interfere with specific molecular pathways within cells. These inhibitors function by targeting proteins or enzymes associated with the regulation of signaling pathways, particularly those involved in cellular proliferation and survival. Structurally, the inhibitors are characterized by their unique scaffold, which allows them to bind selectively to their target proteins, typically through competitive inhibition at the active site or an allosteric site. The chemical composition often includes aromatic rings, heterocyclic cores, and various functional groups like amides, esters, or halogen substituents, contributing to their binding affinity and specificity. The molecular design of EG665149 inhibitors is crafted to optimize interactions with the target's binding pocket, often guided by structural biology techniques, such as X-ray crystallography or computational modeling, to enhance binding efficacy and stability.
The binding of EG665149 inhibitors to their targets induces conformational changes or inhibits key enzymatic activities, leading to a disruption of downstream signaling cascades. This mechanism of action can have profound effects on cellular behavior, influencing processes like gene expression, apoptosis, and cell cycle progression. The inhibitors are often tested for their specificity and potency against a range of cellular targets to refine their chemical structure for better efficacy. Additionally, their solubility, permeability, and stability are critical factors in their design to ensure they maintain functionality under various biological conditions. The development and study of EG665149 inhibitors contribute to understanding cellular pathways and mechanisms that are fundamental to molecular biology, making them valuable tools for biochemical research and molecular pathway elucidation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits RNA synthesis, which can affect the transcription of Sox5os5. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, potentially reducing the expression of Sox5os5. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits transcription elongation by RNA polymerase II, which can decrease Sox5os5 levels. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits the transcription of a broad range of genes, which may include Sox5os5. | ||||||
Quinacrine, Dihydrochloride | 69-05-6 | sc-204222 sc-204222B sc-204222A sc-204222C sc-204222D | 100 mg 1 g 5 g 200 g 300 g | $46.00 $57.00 $87.00 $3257.00 $4821.00 | 4 | |
Binds to DNA and can alter transcription, potentially affecting Sox5os5 expression. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Inhibits RNA synthesis by terminating RNA chain elongation, which might affect Sox5os5 levels. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits nuclear export of RNA, which could impact the localization and function of Sox5os5. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
Inhibits RNA polymerase I, and might indirectly affect Sox5os5 expression by altering cellular transcriptional landscape. | ||||||
(+)-Irinotecan | 97682-44-5 | sc-269253 | 10 mg | $62.00 | 1 | |
Inhibits topoisomerase I, leading to DNA damage and potential downstream effects on Sox5os5 expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Inhibits topoisomerase II, causing DNA damage and potentially affecting Sox5os5 expression. | ||||||